A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404)
NCT02109874
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis
Interventions
BIOLOGICAL:
AERAS-404 (mcg H4/nmol IC31)
BIOLOGICAL:
Sterile buffer containing 10 mmol/L tris and 169 mmol/L NaCl
Sponsor
Aeras
Collaborators
[object Object]